AOD-9604
Typical dose
300 mcg
once daily (fasted AM) · SubQ
Half-life
20-60 minutes
What is AOD-9604?
Modified HGH fragment designed specifically for fat loss without affecting blood sugar or IGF-1. Originally developed as an obesity drug.
How AOD-9604 works
Mimics HGH lipolytic action without its metabolic effects.
Benefits & uses
- Fat loss
- Lipolysis stimulation
- No insulin effects
- Cartilage repair (secondary)
Common uses: Fat loss, lipolysis stimulation, body composition support.
AOD-9604 dosage
- Typical dose
- Typical: 300 mcg/day SubQ (often fasted AM). 8–12 weeks.
- Protocol notes
- 300-500mcg per injection, once daily fasted.
AOD-9604 half-life
20-60 minutes
AOD-9604 side effects
Minimal reported.
- Minimal reported
- Mild injection site reactions
Warnings & monitoring
- Research use only
Preparation & storage
- Preparation
- Mix a 5 mg vial with 2 mL bac water → 2,500 mcg/mL. A 300 mcg dose = 0.12 mL = 12 units.
- Reconstitution
- Reconstitute a 5 mg vial with 2 mL BAC water → 2.5 mg/mL. A 300 mcg dose = 0.12 mL = 12 units on a U-100 syringe.
- Storage
- Lyophilized: refrigerate (2–8 °C). Reconstituted: refrigerate, use within 30 days.
AOD-9604 interactions
with Semaglutide
Caution · moderateAOD-9604 is a GH fragment claimed to stimulate lipolysis; semaglutide reduces caloric intake via GLP-1 agonism. Stacking multiple fat-loss mechanisms may cause excessive caloric deficit and muscle loss.
Timing: Avoid combining multiple fat-loss agents without medical supervision
with Semaglutide
Caution · mildBoth compounds promote fat loss via different mechanisms (lipolysis vs appetite suppression) — additive effect can cause excessive caloric restriction and muscle catabolism.
Timing: Start semaglutide dose at the lowest level when combining; monitor appetite closely
with CJC-1295
CompatibleAOD-9604 targets fat metabolism without binding the GH receptor; pairs cleanly with GHRH analogs for body-comp protocols.
Timing: AOD-9604 morning + CJC nightly
